IC2PerMed Meeting in Rome

WFPHA is one of the partners of the project Integrating China in the International Consortium for Personalised Medicine (IC2PerMed). This project aims to support EU-China collaboration on different aspects of personalised cancer medicine, such as research, innovation and policy developments, providing people with access to personalised, effective and inclusive healthcare solutions in the near future.

From 9 to 10 June 2022, WFPHA delegates Prof. Bettina Borisch and Dr. Marta Lomazzi met with the other consortium partners at the Università Cattolica del Sacro Cuore in Rome, Italy, to validate a roadmap for the China’s integration.

WFPHA will organise a dedicated webinar to present the roadmap on 11 October 2022 and a high-level meeting in May 2023 to share evidence and best practice, and to empower public health professionals worldwide.